Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
Active, not recruiting · NCT05417789 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse type | Active, not recruiting | Phase 3 | 2026-07-29 | NCT05417789 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SynOx Therapeutics Limited | 1 |
33 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.